Volume 11, Number 1—January 2005
Research
Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001
Edward A. Belongia*
, Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§
, Burney Kieke*, Ruth Lynfield†, Jeffrey P. Davis‡, and Richard E. Besser§Table
Characteristics of Minnesota and Wisconsin clinicians who received requests for antimicrobial agents to prevent anthrax during the last quarter of 2001
| Received requests (%) | p value | |
|---|---|---|
| Prescriber type | ||
| Physician | 52/157 (33) | <0.001 |
| Nonphysician | 6/52 (12) | |
| Practice location | ||
| Metropolitan area | 22/82 (27) | 0.82 |
| Nonmetropolitan area | 36/128 (28) | |
| State | ||
| Minnesota | 29/105 (28) | 1.0 |
| Wisconsin | 29/105 (28) | |
| Physician specialty* | ||
| Family practice | 26/62 (41) | 0.61 |
| Internal medicine | 14/42 (30) | |
| Pediatrics | 8/28 (28) | |
| Emergency medicine | 2/5 (33) |
*Nine physicians who listed 2 specialties and 2 who listed “other” as a specialty were excluded from the frequency distribution for physician specialty.
